Spero Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
SPRO Nasdaq 8731 https://sperotherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Spero Therapeutics Inc

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 31st, 2023 8:05 pm
Time To Worry? Analysts Are Downgrading Their Spero Therapeutics, Inc. (NASDAQ:SPRO) Outlook - May 18th, 2023 11:09 am
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q1 2023 Earnings Call Transcript - May 16th, 2023 3:36 pm
Q1 2023 Spero Therapeutics Inc Earnings Call - May 12th, 2023 9:30 am
Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Tops Revenue Estimates - May 11th, 2023 9:35 pm
Spero Therapeutics Announces First Quarter 2023 Operating Results and Provides a Business Update - May 11th, 2023 8:05 pm
Spero Therapeutics to Provide Business Update and Report First Quarter 2023 Financial Results on Thursday, May 11, 2023 - May 4th, 2023 12:05 pm
Spero Therapeutics to Present at Upcoming Investor Conference - Apr 26th, 2023 12:05 pm
Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Price Is Right But Growth Is Lacking After Shares Rocket 26% - Apr 17th, 2023 11:14 am
Spero Therapeutics to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious Diseases - Apr 14th, 2023 12:05 pm
Industry Analysts Just Upgraded Their Spero Therapeutics, Inc. (NASDAQ:SPRO) Revenue Forecasts By 40% - Apr 13th, 2023 10:19 am
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2022 Earnings Call Transcript - Apr 6th, 2023 1:59 am
Spero Therapeutics (NASDAQ:SPRO) Is In A Strong Position To Grow Its Business - Apr 1st, 2023 1:07 pm
Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Beat Estimates - Mar 30th, 2023 10:05 pm
Spero Therapeutics Announces Fourth Quarter and Full Year 2022 Operating Results and Provides Business Update - Mar 30th, 2023 8:05 pm
Spero Therapeutics Reschedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call to March 30, 2023 - Mar 13th, 2023 12:05 pm
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on Monday, March 13, 2023 - Mar 6th, 2023 1:05 pm
Spero Therapeutics to Present at Upcoming Investor Conferences - Feb 28th, 2023 1:05 pm
Down -12.5% in 4 Weeks, Here's Why Spero Therapeutics, Inc. (SPRO) Looks Ripe for a Turnaround - Feb 23rd, 2023 2:35 pm
Spero Therapeutics, Inc. (SPRO) Loses -9.78% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Feb 22nd, 2023 2:35 pm